Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 18 Sarcoma 15 Burkitt Lymphoma 9 Breast Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Neoplasm Metastasis 8 Triple Negative Breast Neoplasms 7 Lymphoma, T-Cell, Peripheral 7 Lymphoma, Follicular 7 Lymphoma, B-Cell 7 Ovarian Neoplasms 6 Lymphoma 6 Hodgkin Disease 6 Endometrial Neoplasms 5 Osteosarcoma 4 Neuroblastoma 4 Lymphoma, Non-Hodgkin 4 Liposarcoma 4 Recurrence 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Peritoneal Neoplasms 3 Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Leiomyosarcoma 3 Histiocytoma, Malignant Fibrous 3 Hemangiosarcoma 3 Colorectal Neoplasms 3 Uterine Neoplasms 2 Stomach Neoplasms 2 Sarcoma, Synovial 2

Interventions

Cryosurgery 3 nirogacestat 2 trifluridine tipiracil drug combination 1 X-Rays 1 Specimen Handling 1 Phantoms, Imaging 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 High-Intensity Focused Ultrasound Ablation 1 Fluorouracil 1 Embolization, Therapeutic 1 Doxorubicin 1 Cryotherapy 1 Bone Density 1 Bevacizumab 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Desmoid Tumors × Doxorubicin × Clear all

NCT06268457 2026-05-14

Embodesmo

Istituto Ortopedico Rizzoli

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡